April 16, 2008
Evonik Industries and Sabinsa Group, a whollyowned
subsidiary of Sami Labs Ltd., India have elevated their exclusive marketing
partnership with the Personal Care product line of Evonik on a new level. Evonik will
now offer more specialized, standardized botanical actives & extracts from Sabinsa, all
specifically developed for cosmeceutical use, to the personal care industry worldwide.
This new agreement deepens the one year old partnership and enables Sabinsa to get
their innovative and efficacious active ingredients into the global cosmetic and personal
care market by tapping into Evonik's extensive customer base.
Willy Klipp, Senior Vice President & General Manager of Evonik's business line Care Specialties,
state "Collaborating with Sabinsa has allowed us to strategically broaden our ingredients
portfolio with novel nature-derived active ingredients. As these bio-active compounds exactly
meet the needs of our customers, we want to offer them now another two Sabinsa cosmeceuticals
for the development of innovative products and new applications."
Shortly Evonik will introduce Venocin™(90%), a standardized extract derived from the seeds of
the Horse Chestnut tree for the cosmetic market. Horse chestnut extract is clinically proven to
benefit people suffering for example from varicose or spider veins. The second "new entry" is
Xymenynic Acid, obtained from Santalum album seeds. The standardized powder extract adds an
anti-inflammatory effect to personal care products. These products will complement the already
existing range of new plant extracts originating from the cooperation with Sabinsa: Tego®
Galanga, obtained from the roots of Kaempferia galangal; Tego® Policosanol, a mixture of higher
aliphatic alcohols extracted from sugar cane wax; Tego® Arjuna, a standardized extract from the
heartwood of the Terminalia Arjuna tree; and Tego® Turmerone, a distilled fraction of turmeric oil
from the root of Curuma longa by a supercritical carbon dioxide process.
These products are produced at Sami Labs Ltd., Sabinsa's national award winning research centre
in Bangalore, India and have been tested for safety and efficacy in their biological research
laboratory by advanced in vitro systems like cell lines and bioassays.
"At the first anniversary of our marketing partnership, we are pleased to announce that this
successful collaboration has reached a new level. Working with Evonik's business line Care
Specialties not only allows us to strengthen the market penetration for our line of active
ingredients for the cosmetic industry, but permits us to focus on our core competency of
developing safe and effective ingredients for the global market. By leveraging the key strengths
of both companies, we are confident we can develop and deliver even more innovative and
efficacious products that meet the needs of consumers", stated Dr. Muhammed Majeed, founder
and CEO of Sabinsa Group.
Company information
Evonik Industries is the creative industrial group from Germany which operates in three business
areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an
expert in power generation from hard coal and renewable energies, and one of the largest private
residential real estate companies in Germany. Our strengths are creativity, specialization,
continuous self-renewal, and reliability. Evonik is active in over 100 countries around the world.
In its fiscal year 2007 about 43,000 employees generated sales of about €14.4 billion and an
operating profit (EBIT) of more than €1.3 billion (preliminary figures).
Sabinsa Group, founded in 1988 in USA, is a manufacturer and supplier of herbal extracts,
cosmeceuticals and fine, specialty and intermediatory chemicals. Sabinsa's mission is to provide
alternative and complementary natural products for human well-being. Over the past nine years,
Sabinsa has brought to market more than thirty standardized botanical extracts and privately
funded several clinical studies in conjunction with prestigious institutions in support of these
products. With more than 100 scientists working full time conducting ongoing research both in
India and the United States, Sabinsa continues to develop and patent cosmeceuticals for the
world market. For more information visit www.sabinsa.com, www.sabinsaeurope.com and
www.sabinsacosmetics.com.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements
concern the future, these forecasts, expectations or statements may involve known or unknown
risks and uncertaties. Actual results or developments may vary, depending on changes in the
operating environment. Neither Evonik Industries AG nor its group companies assume an
obligation to update the forecasts, expectations or statements contained in this release.
